EF
MRK icon

Empowered Funds’s Merck MRK Stock Holding History

Empowered Funds’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-45,385
Closed -$5.04M – 638
2022
Q4 		$5.04M Buy
+45,385
New +$4.64M 0.33% 85

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Empowered Funds's MRK Position: Q1 2026 in Review

Empowered Funds reduced its Merck (MRK) stake by 26% in Q1 2026, selling an estimated $20.6M and leaving 507,815 shares worth $61.1M. The position accounts for 0.39% of the portfolio, ranked #29.

Empowered Funds first reported a position in MRK in Q3 2022 and has held it in 14 quarters since. The position peaked at $72.2M in Q4 2025. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Empowered Funds held 507,815 shares of Merck worth $61.1M as of Q1 2026.
  • Empowered Funds sold 178,382 Merck shares in Q1 2026, an estimated $20.6M.
  • Merck made up 0.39% of Empowered Funds's portfolio in Q1 2026, its #29 holding.
  • Empowered Funds first reported a position in Merck in Q3 2022 and has held it in 14 quarters since.
  • Empowered Funds's Merck position peaked at $72.2M in Q4 2025.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.